The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
Release Date:
A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce